Amsterdam Rheumatology & immunology Center (ARC)

Research facility

Amsterdam, Netherlands

Publications in cooperation with FAU scientists

Glatt, S., Taylor, P.C., McInnes, I.B., Schett, G., Landewe, R.L., Baeten, D.,... Shaw, S. (2019). Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: A proof-of-concept study. Annals of the Rheumatic Diseases.
Winthrop, K.L., Weinblatt, M.E., Crow, M.K., Burmester, G.R., Mease, P.J., So, A.K.,... Furst, D.E. (2019). Unmet need in rheumatology: Reports from the Targeted Therapies meeting 2018. Annals of the Rheumatic Diseases, 78(7), 872-878.
Van Steenbergen, H.W., Aletaha, D., Beaart-Van De Voorde, L.J.J., Brouwer, E., Codreanu, C., Combe, B.,... Van Der Helm-Van Mil, A.H.M. (2016). EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Annals of the Rheumatic Diseases.
Gossec, L., Smolen, J.S., Ramiro, S., De Wit, M., Cutolo, M., Dougados, M.,... Van Der Heijde, D. (2016). European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75(3), 499-510.
Schett, G., Emery, P., Tanaka, Y., Burmester, G., Pisetsky, D.S., Naredo, E.,... Van Vollenhoven, R. (2016). Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Annals of the Rheumatic Diseases, 75(8), 1428-37.

Last updated on 2017-12-04 at 08:41